Option Care Health (OPCH) to Announce Quarterly Earnings on Wednesday

Posted by George Bondi on Jul 22nd, 2026

Option Care Health (NASDAQ:OPCH – Get Free Report) is anticipated to post its Q2 2026 results before the market opens on Wednesday, July 29th. Analysts expect the company to announce earnings of $0.42 per share and revenue of $1.4181 billion for the quarter. Option Care Health has set its FY 2026 guidance at 1.820-1.920 EPS. Individuals may review the information on the company’s upcoming Q2 2026 earning report page for the latest details on the call scheduled for Wednesday, July 29, 2026 at 8:30 AM ET.

Option Care Health (NASDAQ:OPCH – Get Free Report) last posted its earnings results on Thursday, April 30th. The company reported $0.40 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.37 by $0.03. The firm had revenue of $1.35 billion for the quarter, compared to analyst estimates of $1.39 billion. Option Care Health had a return on equity of 18.17% and a net margin of 3.64%.Option Care Health’s revenue was up 1.3% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.40 EPS. On average, analysts expect Option Care Health to post $2 EPS for the current fiscal year and $2 EPS for the next fiscal year.

Option Care Health Price Performance

Shares of NASDAQ:OPCH opened at $21.67 on Wednesday. The company has a debt-to-equity ratio of 0.85, a quick ratio of 1.07 and a current ratio of 1.64. The business’s fifty day moving average price is $21.23 and its two-hundred day moving average price is $27.32. The stock has a market cap of $3.40 billion, a PE ratio of 16.80, a price-to-earnings-growth ratio of 1.21 and a beta of 0.65. Option Care Health has a one year low of $18.01 and a one year high of $36.80.

Insiders Place Their Bets

In related news, Director Timothy P. Sullivan acquired 24,154 shares of Option Care Health stock in a transaction on Thursday, May 7th. The shares were bought at an average price of $20.69 per share, for a total transaction of $499,746.26. Following the completion of the purchase, the director directly owned 73,383 shares in the company, valued at $1,518,294.27. This trade represents a 49.06% increase in their position. The purchase was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director Harry M. Jansen Kraemer, Jr. bought 36,610 shares of the stock in a transaction dated Monday, May 4th. The stock was bought at an average price of $21.41 per share, with a total value of $783,820.10. Following the purchase, the director owned 450,000 shares of the company’s stock, valued at approximately $9,634,500. This represents a 8.86% increase in their position. The disclosure for this purchase is available in the SEC filing. Insiders acquired a total of 73,264 shares of company stock worth $1,548,316 over the last ninety days. 1.70% of the stock is owned by company insiders.

Institutional Investors Weigh In On Option Care Health

Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Advisory Services Network LLC acquired a new stake in shares of Option Care Health during the third quarter valued at about $35,000. McIlrath & Eck LLC purchased a new position in Option Care Health in the second quarter valued at about $37,000. Caitong International Asset Management Co. Ltd purchased a new position in Option Care Health in the third quarter valued at about $38,000. Quarry LP grew its stake in Option Care Health by 502.7% during the 3rd quarter. Quarry LP now owns 1,549 shares of the company’s stock valued at $43,000 after purchasing an additional 1,292 shares in the last quarter. Finally, EverSource Wealth Advisors LLC boosted its stake in shares of Option Care Health by 528.1% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 1,407 shares of the company’s stock valued at $46,000 after buying an additional 1,183 shares during the last quarter. Hedge funds and other institutional investors own 98.05% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of analysts recently commented on the company. Truist Financial set a $30.00 price objective on Option Care Health in a research note on Friday, May 1st. JPMorgan Chase & Co. decreased their price target on shares of Option Care Health from $40.00 to $33.00 and set an “overweight” rating on the stock in a research note on Monday, May 4th. Barrington Research decreased their target price on shares of Option Care Health from $42.00 to $32.00 and set an “outperform” rating on the stock in a research report on Friday, May 1st. TD Cowen lowered their target price on shares of Option Care Health from $37.00 to $23.00 and set a “hold” rating for the company in a research note on Friday, May 1st. Finally, The Goldman Sachs Group began coverage on Option Care Health in a report on Monday, June 8th. They set a “neutral” rating and a $22.00 price objective on the stock. Eight research analysts have rated the stock with a Buy rating and six have given a Hold rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $30.08.

Get Our Latest Research Report on Option Care Health

About Option Care Health

(Get Free Report)

Option Care Health (NASDAQ: OPCH) is a leading provider of home and alternate site infusion services in the United States. The company specializes in the administration of injectable therapies, including antibiotics, nutrition, hydration, immunoglobulin, pain management and specialty pharmaceuticals. Through its nationwide network of infusion pharmacies and nursing professionals, Option Care Health delivers customized care plans and in-home nursing visits to patients managing complex or chronic conditions outside of a hospital setting.

Option Care Health traces its current structure to the completion of its merger with BioScrip in early 2021, combining two of the industry’s most experienced home infusion businesses.